This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Okamoto, Y. Articles by Nakagawara, A. Search for Related Content PubMed PubMed Citation Articles by Okamoto, Y. Articles by Nakagawara, A.

UbcH10 Is the Cancer-related E2 Ubiquitin-conjugating Enzyme¹

Division of Biochemistry, Chiba Cancer Center Research Institute, Chiba 260-8717, Japan [Y. O., T. O., K. M., M. A., A. N.], and Department of General Surgery, Graduate School of Medicine, Chiba University, Chiba 260-0856, Japan [Y. O., M. M.]

Ubiquitin-dependent proteolysis by the 26S proteasome plays a pivotal role in cell cycle progression as well as in tumorigenesis. In this pathway, ubiquitin-conjugating enzyme (E2), together with ubiquitin ligase (E3), transfers ubiquitin to the specific substrate protein(s); however, little is known about the potential contribution of E2 to tumorigenesis. In this study, we examined the expression levels of 17 E2 genes in 25 different human normal tissues and 24 human cancerous cell lines by using a quantitative real-time reverse transcription-PCR. Among the E2 gene family, the expression level of UbcH10 was extremely low in many of the normal tissues but prominent in the majority of cancerous cell lines. Intriguingly, UbcH10 was expressed at high levels in primary tumors derived from the lung, stomach, uterus, and bladder as compared with their corresponding normal tissues, suggesting that UbcH10 is involved in tumorigenesis or progression of the tumor. To further investigate a possible contribution of UbcH10 to malignant transformation and tumor cell proliferation, NIH3T3 cells were transfected with the expression plasmid encoding UbcH10, and stable transfectants were subsequently established. UbcH10-overexpressing cells exhibited an increased incorporation of bromodeoxyuridine, an enhanced growth rate, an increase in saturation density, and a promotion of colony formation in soft agar medium as compared with parental NIH3T3 cells and the control transfectants. Collectively, our present results provide the first evidence that UbcH10 is highly expressed in various human primary tumors and that UbcH10 has an ability to promote cell growth and malignant transformation.

This article has been cited by other articles:

				C. Laurell, D. Velazquez-Fernandez, K. Lindsten, C. Juhlin, U. Enberg, J. Geli, A. Hoog, M. Kjellman, J. Lundeberg, B. Hamberger, et al. Transcriptional profiling enables molecular classification of adrenocortical tumours Eur. J. Endocrinol., July 1, 2009; 161(1): 141 - 152. [Abstract] [Full Text] [PDF]

				M.-H. Chiang, L.-F. Chen, and H. Chen Ubiquitin-Conjugating Enzyme UBE2D2 Is Responsible for FBXW2 (F-Box and WD Repeat Domain Containing 2)-Mediated Human GCM1 (Glial Cell Missing Homolog 1) Ubiquitination and Degradation Biol Reprod, November 1, 2008; 79(5): 914 - 920. [Abstract] [Full Text] [PDF]

				A. Walker, C. Acquaviva, T. Matsusaka, L. Koop, and J. Pines UbcH10 has a rate-limiting role in G1 phase but might not act in the spindle checkpoint or as part of an autonomous oscillator J. Cell Sci., July 15, 2008; 121(14): 2319 - 2326. [Abstract] [Full Text] [PDF]

				C. P. Grou, A. F. Carvalho, M. P. Pinto, S. Wiese, H. Piechura, H. E. Meyer, B. Warscheid, C. Sa-Miranda, and J. E. Azevedo Members of the E2D (UbcH5) Family Mediate the Ubiquitination of the Conserved Cysteine of Pex5p, the Peroxisomal Import Receptor J. Biol. Chem., May 23, 2008; 283(21): 14190 - 14197. [Abstract] [Full Text] [PDF]

				I. Perez de Castro, G. de Carcer, and M. Malumbres A census of mitotic cancer genes: new insights into tumor cell biology and cancer therapy Carcinogenesis, May 1, 2007; 28(5): 899 - 912. [Abstract] [Full Text] [PDF]

				J. K. Choi, U. Yu, O. J. Yoo, and S. Kim Differential coexpression analysis using microarray data and its application to human cancer Bioinformatics, December 15, 2005; 21(24): 4348 - 4355. [Abstract] [Full Text] [PDF]

				M. Bredel, C. Bredel, D. Juric, G. R. Harsh, H. Vogel, L. D. Recht, and B. I. Sikic Functional Network Analysis Reveals Extended Gliomagenesis Pathway Maps and Three Novel MYC-Interacting Genes in Human Gliomas Cancer Res., October 1, 2005; 65(19): 8679 - 8689. [Abstract] [Full Text] [PDF]

				Z. Wang, H. K. Chua, A. A. R. A. Gusti, F. He, B. Fenner, I. Manopo, H. Wang, and J. Kwang RING-H2 Protein WSSV249 from White Spot Syndrome Virus Sequesters a Shrimp Ubiquitin-Conjugating Enzyme, PvUbc, for Viral Pathogenesis J. Virol., July 15, 2005; 79(14): 8764 - 8772. [Abstract] [Full Text] [PDF]

				M. Port, H.U. Schmelz, M. Stockinger, C. Sparwasser, P. Albers, T. Pottek, and M. Abend Gene Expression Profiling in Seminoma and Nonseminoma J. Clin. Oncol., January 1, 2005; 23(1): 58 - 69. [Abstract] [Full Text] [PDF]

				M. K. Saville, A. Sparks, D. P. Xirodimas, J. Wardrop, L. F. Stevenson, J.-C. Bourdon, Y. L. Woods, and D. P. Lane Regulation of p53 by the Ubiquitin-conjugating Enzymes UbcH5B/C in Vivo J. Biol. Chem., October 1, 2004; 279(40): 42169 - 42181. [Abstract] [Full Text] [PDF]